John Inge Johnsen
Principal Researcher | Docent
E-mail: john.inge.johnsen@ki.se
Visiting address: Widerströmska huset, hiss 1, plan 8 Tomtebodavägen 18A, 17177 Stockholm
Postal address: K6 Kvinnors och barns hälsa, K6 Barnonkologi och Barnkirurgi Kogner/Johnsen, 171 77 Stockholm
Part of:
- Department of Women's and Children's Health
- Pediatric Oncology and Pediatric Surgery
- Per Kogner and John Inge Johnsen research group
About me
- Dr. John Inge Johnsen received his PhD diploma at University of Tromsö,
Norway under the supervision of Professor Terje Traavik in 1994. His thesis
focused on the characterization of regulatory genetic elements in
polyomaviruses and the effects these regulatory regions have on host/virus
interaction.
After finishing his PhD, Dr. Johnsen went on to pursue his main scientific
interest; cancer biology, oncogenes and tumor suppressor genes and 1995 he
joined Professor Eric Stanbridge´s research group at University of
California, Irvine where he studied the effects of p53 and genes regulated by
p53 on cancer development.
After spending two years at the University of Tromsö as an assistant
professor/lecturer Dr. Johnsen joined professor Per Kogner´s research group
at Karolinska Institutet as a postdoctoral fellow where he together with Dr.
Kogner built up the childhood neural tumor research consortium.
Dr. Johnsen became Associate professor at Karolinska Instituet in 2010.
1984-1990 Msc, University of Tromsö, Norway
1991-1994 PhD, University of Tromsö, Norway
1995-1997 Postdoc, Dr.Stanbridge´s lab, University of California, Irvine,
USA
1997-1998 Postdoc, Dept. of Pediatrics, University of Tromsö Norway
2001-2003 Postdoc, Childhood Cancer Research Unit, Karolinska Istitutet
Research
- The main focus of our research group is to search for new treatment options
that lead to better survival, less treatment-related complications and better
quality of life for children with medulloblastoma and neuroblastoma. This is
done by applying different Omic techniques to characterize the molecular
landscape of malignant and corresponding non-cancerous cells within the tumor
microenvironment and to use a translational approach applying preclinical in
vivo models to characterize the anti-tumorigenic effects of drugs and
compounds targeting specific biological aberrations in cancer cells or
populations of cells located within the tumor microenvironment.
Articles
- Article: CANCER LETTERS. 2025;625:217769Milosevic J; Fransson S; Svensson J; Otte J; Olsen TK; Sveinbjornsson B; Hertwig F; Bartenhagen C; Abel F; Reinsbach SE; Djos A; Javanmardi N; Shi Y; Hehir-Kwa JY; Mensenkamp A; Tytgat GAM; Holmberg J; Molenaar JJ; Jongmans M; Fischer M; Baryawno N; Gisselsson D; Martinsson T; Kogner P; Johnsen JI
- Article: CANCER RESEARCH. 2025;85(6):1015-1034Embaie BT; Sarkar H; Alchahin AM; Otte J; Olsen TK; Tummler C; Kameneva P; Artemov AV; Akkuratova N; Adameyko I; Stukenborg J-B; Wickstrom M; Kogner P; Johnsen JI; Mei S; Kharchenko PV; Baryawno N
- Article: NEURO-ONCOLOGY. 2025;27(3):779-794van Bree N; Oppelt A-S; Lindstroem S; Zhou L; Boutin L; Coyle B; Swartling FJ; Johnsen JI; Braeutigam L; Wilhelm M
- Article: EMBO JOURNAL. 2024;43(24):6310-6335Thombare K; Vaid R; Pucci P; Lundberg KI; Ayyalusamy R; Baig MH; Mendez A; Burgos-Panadero R; Hoeppner S; Bartenhagen C; Sjovall D; Rehan AA; Nale SD; Djos A; Martinsson T; Jaako P; Dong J-J; Kogner P; Johnsen JI; Fischer M; Turner SD; Mondal T
- Journal article: NEURO-ONCOLOGY ADVANCES. 2024;6(1):vdae172Ruchiy Y; Tsea I; Preka E; Verhoeven BM; Olsen TK; Mei S; Sinha I; Blomgren K; Carlson L-M; Dyberg C; Johnsen JI; Baryawno N
- Article: CANCER LETTERS. 2024;605:217261Pepich A; Tummler C; Abu Ajamieh S; Treis D; Boje AS; Vellema Q; Tsea I; Akerlund E; Seashore-Ludlow B; Fard SS; Kogner P; Johnsen JI; Wickstrom M
- Journal article: CANCER RESEARCH. 2024;84(17):b060Verhoeven BM; Ye K; Stenman J; Kogner P; Johnsen JI; Reina OB; Kreslavskiy T; Baryawno N
- Article: MOLECULAR CANCER. 2024;23(1):180Olsen TK; Otte J; Mei S; Embaie BT; Kameneva P; Cheng H; Gao T; Zachariadis V; Tsea I; Bjorklund A; Kryukov E; Hou Z; Johansson A; Sundstrom E; Martinsson T; Fransson S; Stenman J; Fard SS; Johnsen JI; Kogner P; Adameyko I; Enge M; Kharchenko PV; Baryawno N
- Article: NUCLEIC ACIDS RESEARCH. 2024;52(5):2648-2671Vaid R; Thombare K; Mendez A; Burgos-Panadero R; Djos A; Jachimowicz D; Lundberg KI; Bartenhagen C; Kumar N; Tummler C; Sihlbom C; Fransson S; Johnsen JI; Kogner P; Martinsson T; Fischer M; Mondal T
- Article: JCI INSIGHT. 2024;9(6):e173337Mei S; Alchahin AM; Embaie BT; Gavriliuc IM; Verhoeven BM; Zhao T; Li X; Jeffries NE; Pepich A; Sarkar H; Olsen TK; Wickstrom M; Stenman J; Reina-Bedoya O; Kharchenko PV; Saylor PJ; Johnsen JI; Sykes DB; Kogner P; Baryawno N
- Article: GENOME MEDICINE. 2024;16(1):1Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu C-L; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
- Article: NEURO-ONCOLOGY ADVANCES. 2024;6(1):vdae172Ruchiy Y; Tsea I; Preka E; Verhoeven BM; Olsen TK; Mei S; Sinha I; Blomgren K; Carlson L-M; Dyberg C; Johnsen JI; Baryawno N
- Article: CANCERS. 2023;15(18):4599Yuan Y; Alzrigat M; Rodriguez-Garcia A; Wang X; Bexelius TS; Johnsen JI; Arsenian-Henriksson M; Liano-Pons J; Bedoya-Reina OC
- Journal article: NEURO-ONCOLOGY. 2023;25(Suppl 1):i62MDB-04. SINGLE-CELL TRANSCRIPTOMIC ANALYSIS REVEALS DISTINCT GENOMIC LANDSCAPES, CELL TRAJECTORIES, AND TUMOUR-MICROENVIRONMENT INTERACTIONS IN FOUR SUBTYPES OF MEDULLOBLASTOMA
- Article: BRITISH JOURNAL OF CANCER. 2022;127(11):2060-2071Zhou X; Santos GS; Zhan Y; Oliveira MMS; Rezaei S; Singh M; Peuget S; Westerberg LS; Johnsen JI; Selivanova G
- Article: JCI INSIGHT. 2022;7(17):e153836Olsen TK; Dyberg C; Embaie BT; Alchahin A; Milosevic J; Ding J; Otte J; Tummler C; Myrberg IH; Westerhout EM; Koster J; Versteeg R; Ding H-F; Kogner P; Johnsen JI; Sykes DB; Baryawno N
- Article: CELL REPORTS MEDICINE. 2022;3(6):100657Verhoeven BM; Mei S; Olsen TK; Gustafsson K; Valind A; Lindstrom A; Gisselsson D; Fard SS; Hagerling C; Kharchenko PV; Kogner P; Johnsen JI; Baryawno N
- Journal article: CANCER RESEARCH. 2022;82(12_Supplement):1677Tsea I; Ruchiy Y; Verhoeven M; Sinha I; Blomgren K; Carlson LM; Johnsen JI; Dyberg C; Baryawno N
- Journal article: CANCER RESEARCH. 2022;82(12_Supplement):6215Verhoeven BM; Mei S; Olsen TK; Gustafsson KK; Valind A; Lindström A; Nord DG; Fard SS; Hagerling C; Kharchenko PV; Kogner P; Johnsen JI; Baryawno N
- Article: LIFE SCIENCES. 2022;295:120394Ljungblad L; Bergqvist F; Tummler C; Madawala S; Olsen TK; Andonova T; Jakobsson P-J; Johnsen JI; Pickova J; Strandvik B; Kogner P; Gleissman H; Wickstrom M
- Article: CANCER RESEARCH COMMUNICATIONS. 2022;2(3):182-201Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickstrom M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson L-G
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;23(7):3702Rasheed K; Moens U; Policastro B; Johnsen JI; Koljonen V; Sihto H; Lui W-O; Sveinbjornsson B
- Article: NATURE COMMUNICATIONS. 2022;13(1):1537Zhang S; Miyakawa A; Wickstrom M; Dyberg C; Louhivuori L; Varas-Godoy M; Kemppainen K; Kanatani S; Kaczynska D; Ellstrom ID; Elfman L; Kronqvist P; Repo H; Mikoshiba K; Sahlgren C; Johnsen JI; Uhlen P
- Article: BMC GENOMICS. 2022;23(1):149Borjesson V; Martinez-Monleon A; Fransson S; Kogner P; Johnsen JI; Milosevic J; Lopez MD
- Article: NEURO-ONCOLOGY ADVANCES. 2022;4(1):vdac028Bandaru S; Prajapati B; Juvvuna PK; Dosa S; Kogner P; Johnsen JI; Kanduri C; Akyurek LM
- Article: JCO PRECISION ONCOLOGY. 2022;6:e2100271Treis D; Umapathy G; Fransson S; Guan J; Mendoza-Garcia P; Siaw JT; Wessman S; Murkes LG; Stenman JJE; Djos A; Elfman LHM; Johnsen JI; Hallberg B; Palmer RH; Martinsson T; Kogner P
- Article: CANCER DISCOVERY. 2021;11(12):3090-3105Zhou X; Singh M; Santos GS; Guerlavais V; Carvajal LA; Aivado M; Zhan Y; Oliveira MMS; Westerberg LS; Annis DA; Johnsen JI; Selivanova G
- Article: CANCERS. 2021;13(23):6042Milosevic J; Treis D; Fransson S; Gallo-Oller G; Sveinbjoernsson B; Eissler N; Tanino K; Sakaguchi K; Martinsson T; Wickstroem M; Kogner P; Johnsen JI
- Article: CANCERS. 2021;13(21):5493Milosevic J; Fransson S; Gulyas M; Olsen TK; Gallo-Oller G; Treis D; Elfman LHM; Wilhelm M; Martinsson T; Baryawno N; Kogner P; Johnsen JI
- Article: CELL DEATH & DISEASE. 2021;12(10):914Giovannucci TA; Salomons FA; Haraldsson M; Elfman LHM; Wickstroem M; Young P; Lundbaeck T; Eirich J; Altun M; Jafari R; Gustavsson A-L; Johnsen JI; Dantuma NP
- Article: PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. 2021;169:102285Ljungblad L; Gleissman H; Hedberg G; Wickstrom M; Eissler N; Pickova J; Johnsen JI; Tedroff K; Strandvik B; Kogner P
- Article: CANCER RESEARCH. 2021;81(6):1457-1471Mitra S; Muralidharan SV; Di Marco M; Juvvuna PK; Kosalai ST; Reischl S; Jachimowicz D; Subhash S; Raimondi I; Kurian L; Huarte M; Kogner P; Fischer M; Johnsen JI; Mondal T; Kanduri C
- Article: FRONTIERS IN ONCOLOGY. 2020;10:598872Xia C; Olsen TK; Zirakzadeh AA; Almamoun R; Sjoholm LK; Dahlstrom J; Sjoberg J; Claesson H-E; Johnsen JI; Winqvist O; Xu D; Ekstrom TJ; Bjorkholm M; Straat K
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(33):20127-20138Susanto E; Navarro AM; Zhou L; Sundstrom A; van Bree N; Stantic M; Moslem M; Tailor J; Rietdijk J; Zubillaga V; Huebner J-M; Weishaupt H; Wolfsberger J; Alafuzoff I; Nordgren A; Magnaldo T; Siesjo P; Johnsen JI; Kool M; Tammimies K; Darabi A; Swartling FJ; Falk A; Wilhelm M
- Article: FASEB JOURNAL. 2020;34(8):11101-11114Kock A; Bergqvist F; Steinmetz J; Elfman LHM; Korotkova M; Johnsen JI; Jakobsson P-J; Kogner P; Larsson K
- Article: CANCERS. 2019;12(1):E73-73Dyberg C; Andonova T; Olsen TK; Brodin B; Kool M; Kogner P; Johnsen JI; Wickstrom M
- Article: ONCOGENE. 2019;38(15):2800-2813Hald OH; Olsen L; Gallo-Oller G; Elfman LHM; Lokke C; Kogner P; Sveinbjornsson B; Flaegstad T; Johnsen JI; Einvik C
- Article: CANCERS. 2019;11(2):E202-202Tummler C; Dumitriu G; Wickstrom M; Coopman P; Valkov A; Kogner P; Johnsen JI; Moens U; Sveinbjornsson B
- Article: CANCER LETTERS. 2019;442:341-350Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG
- Article: EBIOMEDICINE. 2018;32:84-92Kock A; Larsson K; Bergqvist F; Eissler N; Elfman LHM; Raouf J; Korotkova M; Johnsen JI; Jakobsson P-J; Kogner P
- Article: PHARMACOLOGICAL RESEARCH. 2018;131:164-176Johnsen JI; Dyberg C; Fransson S; Wickstrom M
- Article: ONCOTARGET. 2017;8(56):95135-95151Tummler C; Snapkov I; Wickstrom M; Moens U; Ljungblad L; Elfman LHM; Winberg J-O; Kogner P; Johnsen JI; Sveinbjornsson B
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(32):E6603-E6612Dyberg C; Fransson S; Andonova T; Sveinbjornsson B; Lannerholm-Palm J; Olsen TK; Forsberg D; Herlenius E; Martinsson T; Brodin B; Kogner P; Johnsen JI; Wickstrom M
- Journal article: CANCER RESEARCH. 2017;77:687Kock A; Larsson K; Eissler N; Bergqvist F; Rauf J; Korotkova M; Johnsen J-I; Jakobsson P-J; Kogner P
- Journal article: CANCER RESEARCH. 2017;77:1945Milosevic J; Eissler N; Treis D; Wicktrom M; Fransson S; Sveinbjornsson B; Baryawno N; Kosalai S; Kanduri C; Sakaguchi K; Martinsson T; Johnsen JI; Kogner P
- Article: SCIENTIFIC REPORTS. 2017;7:46366Sanden E; Dyberg C; Krona C; Gallo-Oller G; Olsen TK; Perez JE; Wickstrom M; Estekizadeh A; Kool M; Visse E; Ekstrom TJ; Siesjo P; Johnsen JI; Darabi A
- Article: CLINICAL CANCER RESEARCH. 2016;22(15):3849-3859Mao Y; Eissler N; Le Blanc K; Johnsen JI; Kogner P; Kiessling R
- Article: CELL REPORTS. 2016;16(4):979-993Ribeiro D; Klarqvist MDR; Westermark UK; Oliynyk G; Dzieran J; Kock A; Banares CS; Hertwig F; Johnsen JI; Fischer M; Kogner P; Loven J; Henriksson MA
- Article: BMC CANCER. 2016;16:490Snapkov I; Oqvist CO; Figenschau Y; Kogner P; Johnsen JI; Sveinbjornsson B
- Journal article: CANCER RESEARCH. 2016;76:2465Tuemmler C; Dumitriu G; Cserna J; Moens UL; Kogner P; Johnsen JI; Sveinbjornsson B
- Journal article: CANCER RESEARCH. 2016;76:761Bergqvist F; Ljungblad L; Wickstrom M; Larsson K; Kock A; Korotkova M; Johnsen JI; Kogner P; Jakobsson P-J
- Journal article: CANCER RESEARCH. 2016;76:2454Ljungblad L; Bergqvist F; Andonova T; Jakobsson P-J; Johnsen JI; Kogner P; Wickstrom M
- Journal article: NEURO-ONCOLOGY. 2016;18(suppl_3):iii116Ljungblad L; Bergqvist F; Andonova T; Jakobsson P-J; Johnsen JI; Gleissman H; Kogner P; Wickström M
- Journal article: NEURO-ONCOLOGY. 2016;18(Suppl 3):iii116MB-83OMEGA-3 FATTY ACIDS DHA AND EPA SUPPRESS ONCOGENIC PGE2 IN MEDULLOBLASTOMA
- Article: BMC CANCER. 2016;16:259Dyberg C; Papachristou P; Haug BH; Lagercrantz H; Kogner P; Ringstedt T; Wickstrom M; Johnsen JI
- Article: MOLECULAR & CELLULAR ONCOLOGY. 2016;3(2):e1131356Johnsen JI; Wickstrom M; Baryawno N
- Article: DEVELOPMENTAL CELL. 2016;36(2):164-178Li S; Fell SM; Surova O; Smedler E; Wallis K; Chen ZX; Hellman U; Johnsen JI; Martinsson T; Kenchappa RS; Uhlen P; Kogner P; Schlisio S
- Article: ONCOIMMUNOLOGY. 2016;5(12):e1232222Eissler N; Mao Y; Brodin D; Reutersward P; Svahn HA; Johnsen JI; Kiessling R; Kogner P
- Article: NATURE COMMUNICATIONS. 2015;6:8904Wickstrom M; Dyberg C; Milosevic J; Einvik C; Calero R; Sveinbjornsson B; Sanden E; Darabi A; Siesjo P; Kool M; Kogner P; Baryawno N; Johnsen JI
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2015;112(26):8070-8075Larsson K; Kock A; Idborg H; Henriksson MA; Martinsson T; Johnsen JI; Korotkova M; Kogner P; Jakobsson P-J
- Article: JOURNAL OF NEURO-ONCOLOGY. 2015;123(1):1-13Sanden E; Dyberg C; Krona C; Visse E; Caren H; Northcott PA; Kool M; Stahl N; Persson A; Englund E; Johnsen JI; Siesjo P; Darabi A
- Journal article: LINDBERGIA. 2015;38(1):30-38Hassel K; Johnsen JI; Jordal JB; Knutsen A
- Article: BMC CANCER. 2014;14:600Diao Y; Rahman MF-U; Villegas VE; Wickstrom M; Johnsen JI; Zaphiropoulos PG
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2014;450(4):1600-1605Marino A-M; Frijhoff J; Calero R; Baryawno N; Ostman A; Johnsen JI
- Article: PLOS ONE. 2014;9(4):e95628Calero R; Morchon E; Johnsen JI; Serrano R
- Article: CANCER DISCOVERY. 2014;4(4):434-451Chen ZX; Wallis K; Fell SM; Sobrado VR; Hemmer MC; Ramskold D; Hellman U; Sandberg R; Kenchappa RS; Martinson T; Johnsen JI; Kogner P; Schlisio S
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2014;106(3):djt459Eriksson E; Wickstrom M; Perup LS; Johnsen JI; Eksborg S; Kogner P; Savendahl L
- Journal article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2014;2(Suppl 3):p203Eissler N; Sveinbjörnsson B; Kock A; Johnsen JI; Kogner P
- Article: INTERNATIONAL JOURNAL OF CANCER. 2013;133(10):2351-2361Wolmer-Solberg N; Baryawno N; Rahbar A; Fuchs D; Odeberg J; Taher C; Wilhelmi V; Milosevic J; Mohammad A-A; Martinsson T; Sveinbjornsson B; Johnsen JI; Kogner P; Soederberg-Naucler C
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;43(3):831-838Jamil S; Cedervall J; Hultman I; Ali R; Margaryan NV; Rasmuson A; Johnsen JI; Sveinbjornsson B; Dalianis T; Kanter L; Orrego A; Strizzi L; Hendrix MJC; Sandstedt B; Kogner P; Ahrlund-Richter L
- Journal article: CANCER RESEARCH. 2013;73(8_Supplement):2751Wickström M; Baryawno N; Dyberg C; Milosevic J; Sveinbjörnsson B; Northcott PA; Taylor M; Kool M; Kogner P; Johnsen JI
- Journal article: CANCER RESEARCH. 2013;73(8_Supplement):2746Kock A; Rasmuson A; Korotkova M; Idborg H; Johnsen JI; Jakobsson P-J; Kogner P
- Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(7):1516-1524Wickstrom M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevag OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;42(4):1239-1248Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg J-O; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjornsson B
- Article: PLOS ONE. 2012;7(12):e51297Rasmuson A; Segerstrom L; Nethander M; Finnman J; Elfman LHM; Javanmardi N; Nilsson S; Johnsen JI; Martinsson T; Kogner P
- Article: BMC MEDICAL GENETICS. 2012;13:83Kiss NB; Kogner P; Johnsen JI; Martinsson T; Larsson C; Geli J
- Article: BRITISH JOURNAL OF CANCER. 2012;106(11):1807-1815Hiyoshi H; Abdelhady S; Segerstrom L; Sveinbjornsson B; Nuriya M; Lundgren TK; Desfrere L; Miyakawa A; Yasui M; Kogner P; Johnsen JI; Andang M; Uhlen P
- Article: PLOS ONE. 2012;7(1):e29331Rasmuson A; Kock A; Fuskevag OM; Kruspig B; Simon-Santamaria J; Gogvadze V; Johnsen JI; Kogner P; Sveinbjornsson B
- Article: ONCOTARGET. 2011;2(12):1329-1338Johnsen JI; Baryawno N; Soderberg-Naucler C
- Article: INTERNATIONAL JOURNAL OF CANCER. 2011;129(12):2958-2965Segerstrom L; Baryawno N; Sveinbjornsson B; Wickstrom M; Elfman L; Kogner P; Johnsen JI
- Article: CANCER LETTERS. 2011;310(2):222-231Schiapparelli P; Shahi MH; Enguita-German M; Johnsen JI; Kogner P; Lazcoz P; Castresana JS
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2011;121(10):4043-4055Baryawno N; Rahbar A; Wolmer-Solberg N; Taher C; Odeberg J; Darabi A; Khan Z; Sveinbjornsson B; Fuskevag O-M; Segerstrom L; Nordenskjold M; Siesjo P; Kogner P; Johnsen JI; Soderberg-Naucler C
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2011;411(1):208-212Marino A-M; Sofiadis A; Baryawno N; Johnsen JI; Larsson C; Vukojevic V; Ekstrom TJ
- Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(7):1703-1711Gleissman H; Segerstrom L; Hamberg M; Ponthan F; Lindskog M; Johnsen JI; Kogner P
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2011;38(3):843-849Philipova T; Baryawno N; Hartmann W; Pietsch T; Drud H; Johnsen JI; Ekstrom TJ
- Article: CELL CYCLE. 2010;9(13):2548-2554Baryawno N; Sveinbjornsson B; Kogner P; Johnsen JI
- Journal article: CANCER RESEARCH. 2010;70(8_Supplement):4354Baryawno N; Milosevic J; Wickström M; Sveinbjörnsson B; Eksborg S; Kogner P; Johnsen JI
- Article: FASEB JOURNAL. 2010;24(3):906-915Gleissman H; Yang R; Martinod K; Lindskog M; Serhan CN; Johnsen JI; Kogner P
- Journal article: ECANCERMEDICALSCIENCE. 2010;4:156Morgan G; Johnsen JI
- Article: CANCER RESEARCH. 2010;70(1):266-276Baryawno N; Sveinbjornsson B; Eksborg S; Chen C-S; Kogner P; Johnsen JI
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(44):18757-18762Hanaka H; Pawelzik S-C; Johnsen JI; Rakonjac M; Terawaki K; Rasmuson A; Sveinbjornsson B; Schumacher MC; Hamberg M; Samuelsson B; Jakobsson P-J; Kogner P; Radmark O
- Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(5):1227-1234Paimberg E; Johnsen JI; Paulsson J; Gleissman H; Wickstrom M; Edgren M; Ostman A; Kogner P; Lindskog M
- Article: FASEB JOURNAL. 2008;22(10):3525-3536Sveinbjornsson B; Rasmuson A; Baryawno N; Wan M; Pettersen I; Ponthan F; Orrego A; Haeggstrom JZ; Johnsen JI; Kogner P
- Article: NEURO-ONCOLOGY. 2008;10(5):661-674Baryawno N; Sveinbjornsson B; Eksborg S; Orrego A; Segerstrom L; Oqvist CO; Holm S; Gustavsson B; Kagedal B; Kogner P; Johnsen JI
- Article: ONCOGENE. 2008;27(20):2910-2922Johnsen JI; Segerstrom L; Orrego A; Elfman L; Henriksson M; Kagedal B; Eksborg S; Sveinbjornsson B; Kogner P
- Article: MOLECULAR CANCER THERAPEUTICS. 2007;6(9):2409-2417Wickstrom M; Johnsen JI; Ponthan F; Segerstrom L; Sveinbjornsson B; Lindskog M; Lovborg H; Viktorsson K; Lewensohn R; Kogner P; Larsson R; Gullbo J
- Article: CLINICAL CANCER RESEARCH. 2007;13(3):1036-1044Ponthan F; Wickstroem M; Gleissman H; Fuskevag OM; Segerstroem L; Sveinbjoernsson B; Redfern CPF; Eksborg S; Kogner P; Johnsen JI
- Article: INTERNATIONAL JOURNAL OF CANCER. 2006;119(3):493-500Eliassen LT; Berge G; Leknessund A; Wikman M; Lindin I; Lokke C; Ponthan F; Johnsen JI; Sveinbjornsson B; Kogner P; Flægstad T; Rekdal O
- Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(10):2584-2593Lindskog M; Gleissman H; Ponthan F; Castro J; Kogner P; Johnsen JI
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2004;25(6):1849-1857Johnsen JI; Pettersen I; Ponthan F; Sveinbjornsson B; Flægstad T; Kogner P
- Article: CANCER RESEARCH. 2004;64(20):7210-7215Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
- Article: JOURNAL OF MEDICAL VIROLOGY. 2003;70(1):14-19Jorgensen GEK; Hammarin AL; Bratt G; Grandien M; Flægstad T; Johnsen JI
- Article: INTERNATIONAL JOURNAL OF CANCER. 2003;104(4):418-424Ponthan F; Johnsen JI; Klevenvall L; Castro J; Kogner P
- Article: ANTICANCER RESEARCH. 2001;21(6A):3733-3738Langaas V; Shahzidi S; Johnsen JI; Smedsrod B; Sveinbjornsson B
- Article: INTERNATIONAL JOURNAL OF CANCER. 2000;88(5):685-691Johnsen JI; Aurelio ON; Kwaja Z; Jörgensen GE; Pellegata NS; Plattner R; Stanbridge EJ; Cajot JF
- Article: CANCER RESEARCH. 1999;59(5):1160-1163Flægstad T; Andresen PA; Johnsen JI; Asomani SK; Jorgensen GE; Vignarajan S; Kjuul A; Kogner P; Traavik T
- Article: VIRUS RESEARCH. 1997;52(1):61-71Kristoffersen AK; Johnsen JI; Seternes OM; Rollag H; Degré M; Traavik T
- Article: NUCLEIC ACIDS RESEARCH. 1996;24(11):2158-2165Farmer AA; Johnsen JI; Loftus TM; Smith KP; Stanbridge EJ
- Article: JOURNAL OF GENERAL VIROLOGY. 1995;76:1571-1581JOHNSEN JI; SETERNES OM; JOHANSEN T; MOENS U; MANTYJARVI R; TRAAVIK T
- Journal article: JOURNAL OF IMMUNOLOGICAL METHODS. 1994;173(2):149-156HEY AW; JOHNSEN JI; JOHANSEN B; TRAAVIK T
- Show more
All other publications
- Review: CANCERS. 2024;16(10):1863Polychronopoulos PA; Bedoya-Reina OC; Johnsen JI
- Preprint: BIORXIV. 2024van Bree N; Oppelt A-S; Lindström S; Zhou L; Boutin L; Johnsen JI; Bräutigam L; Wilhelm M
- Conference publication: PEDIATRIC BLOOD & CANCER. 2023;70:S107Verhoeven BM; Ye K; Stenman J; Kogner P; Johnsen JI; Baryawno N; Kreslavskiy T
- Conference publication: NEURO-ONCOLOGY. 2023;25:i62Ruchiy Y; Tsea I; Verhoeven BM; Sinha I; Preka E; Olsen TK; Mei S; Blomgren K; Johnsen JI; Carlson L-M; Dyberg C; Baryawno N
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson L-G
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson L-G
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson L-G
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson L-G
- Conference publication: CANCER SCIENCE. 2023;114:249Selivanova G; Zhou X; Singh M; Sanz G; Guerlavais V; Carvajal LA; Aivado M; Annis A; Zhan Y; Oliveira M; Westerberg L; Johnsen JI
- Preprint: BIORXIV. 2022Vaid R; Thombare K; Mendez A; Burgos-Panadero R; Djos A; Jachimowicz D; Lundberg KI; Bartenhagen C; Kumar N; Tümmler C; Sihlbom C; Fransson S; Johnsen JI; Kogner P; Martinsson T; Fischer M; Mondal T
- Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S211-S212Alchahin A; Embaie BT; Mei S; Verhoeven BM; Olsen T; Kharchenko P; Johnsen JI; Kogner P; Baryawno N
- Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S211Abu Ajamieh S; Andonova T; Pepich A; Olsen T; Tummler C; Thankaswamy-Kosalai S; Kanduri C; Fransson S; Martinsson T; Baryawno N; Nasman A; Kogner P; Johnsen JI; Wickstrom M
- Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S227Pepich A; Tummler C; Abu Ajamieh S; Vellema Q; Akerlund E; Treis D; Seashore-Ludlow B; Kogner P; Johnsen JI; Wickstrom M
- Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S226Otte J; Olsen T; Mei S; Kameneva P; Embaie BT; Bjorklund A; Johansson A; Sundstrom E; Martinsson T; Fransson S; Stenman J; Cheng H; Zachariadis V; Enge M; Johnsen JI; Kogner P; Adameyko I; Kharchenko P; Baryawno N
- Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S229-S230Tsea I; Olsen T; Otte J; Mei S; Embaie BT; Kogner P; Johnsen JI; Baryawno N; Fard S
- Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S229Treis D; Tummler C; Kogner P; Johnsen JI; Nasman MW
- Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S230Tummler C; Pepich A; Vellema Q; Abu Ajamieh S; Park SW; Ljungblad L; Seashore-Ludlow B; Karlsson K; Kogner P; Johnsen JI; Nasman MW
- Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69Verhoeven BM; Mei S; Olsen T; Gustafsson K; Valind A; Nord DG; Fard S; Hagerling C; Kharchenko P; Kogner P; Johnsen JI; Baryawno N
- Review: CURRENT ONCOLOGY REPORTS. 2022;24(8):1053-1062Lundberg KI; Treis D; Johnsen JI
- Conference publication: CANCER RESEARCH. 2022;82(12)Tsea I; Ruchiy Y; Verhoeven M; Sinha I; Blomgren K; Carlson LM; Johnsen JI; Dyberg C; Baryawno N
- Conference publication: CANCER RESEARCH. 2022;82(12)Verhoeven BM; Mei S; Olsen TK; Gustafsson KK; Valind A; Lindstrom A; Nord DG; Fard SS; Hagerling C; Kharchenko PV; Kogner P; Johnsen JI; Baryawno N
- Conference publication: CANCER RESEARCH. 2022;82(12)Verhoeven BM; Mei S; Olsen TK; Gustafsson KK; Valind A; Lindstrom A; Nord DG; Fard SS; Hagerling C; Kharchenko PV; Kogner P; Johnsen JI; Baryawno N
- Preprint: BIORXIV. 2021Olsen TK; Dyberg C; Embaie B; Alchahin A; Milosevic J; Otte J; Tümmler C; Myrberg IH; Westerhout E; Koster J; Versteeg R; Kogner P; Johnsen JI; Sykes D; Baryawno N
- Preprint: BIORXIV. 2021Giovannucci T; Salomons F; Haraldsson M; Elfman L; Wickström M; Young P; Lundbäck T; Eirich J; Altun M; Jafari R; Gustavsson A-L; Johnsen JI; Dantuma N
- Review: FRONTIERS IN ONCOLOGY. 2021;10:624079Otte J; Dyberg C; Pepich A; Johnsen JI
- Conference publication: PEDIATRIC BLOOD & CANCER. 2020;67:S3Olsen TK; Otte J; Mei S; Kameneva P; Bjorklund A; Kryukov E; Hou Z; Johansson A; Sundstrom E; Martinsson T; Fransson S; Johnsen JI; Kogner P; Adameyko I; Kharchenko P; Baryawno N
- Preprint: BIORXIV. 2020Milosevic J; Fransson S; Gulyas M; Gallo-Oller G; Olsen T; Treis D; Wickström M; Elfman LHM; Sveinbjornsson B; Hertwig F; Bartenhagen C; Reinsbach S; Wilhelm M; Abel F; Javanmardi N; Thankaswamy-Kosalai S; Eissler N; Kock A; Shi Y; Tanino K; Hehir-Kwa J; Mensenkamp A; Tytgat GAM; Kanduri C; Holmberg J; Gisselsson D; Molenaar J; Jongmans M; Fischer M; Kool M; Sakaguchi K; Baryawno N; Martinsson T; Johnsen JI; Kogner P
- Preprint: BIORXIV. 2020Olsen T; Otte J; Mei S; Kameneva P; Björklund Å; Kryukov E; Hou Z; Johansson A; Sundström E; Martinsson T; Fransson S; Johnsen JI; Kogner P; Adameyko I; Kharchenko P; Baryawno N
- Preprint: SSRN ELECTRONIC JOURNAL. 2020Giovannucci TA; Salomons FA; Martin Haraldsson M; Elfman LMH; Wickström M; Young P; Lundbäck T; Eirich J; Altun M; Jafari R; Gustavsson A-L; Johnsen JI; Dantuma N
- Review: FRONTIERS IN MOLECULAR NEUROSCIENCE. 2019;12:9Johnsen JI; Dyberg C; Wickstrom M
- Conference publication: CANCER RESEARCH. 2018;78(13):4145Andonova T; Kogner P; Johnsen JI; Wickstrom M
- Conference publication: CANCER RESEARCH. 2018;78(13):5092Gallo-Oller G; Azatyan A; Baryawno N; Kogner P; Johnsen JI
- Conference publication: PEDIATRIC BLOOD & CANCER. 2017;64:S232Kogner P; Treis D; Siaw J; Fransson S; Guan J; Svenberg P; Hansson M; Wessman S; Gordon L; Stenman J; Svensson PJ; Johnsen JI; Martinsson T; Palmer RH; Hallberg B
- Conference publication: PEDIATRIC BLOOD & CANCER. 2017;64:S343Ljungblad L; Wickstrom M; Eissler N; Pickova J; Johnsen JI; Tedroff K; Strandvik B; Gleissman H; Kogner P
- Review: EXPERT OPINION ON DRUG DISCOVERY. 2017;12(8):801-811Moreno L; Caron H; Geoerger B; Eggert A; Schleiermacher G; Brock P; Valteau-Couanet D; Chesler L; Schulte JH; De Preter K; Molenaar J; Schramm A; Eilers M; Van Maerken T; Johnsen JI; Garrett M; George SL; Tweddle DA; Kogner P; Berthold F; Koster J; Barone G; Tucker ER; Marshall L; Herold R; Sterba J; Norga K; Vassal G; Pearson ADJ
- Conference publication: CANCER RESEARCH. 2017;77:5832Dyberg CH; Fransson S; Andonova T; Sveinbjornsson B; Lannerholm-Palm J; Forsberg D; Herlenius E; Martinsson T; Kogner P; Johnsen JI; Wickstrom M
- Conference publication: PEDIATRIC BLOOD & CANCER. 2016;63:S82Milosevic J; Fransson S; Treis D; Tanino K; Wickstrom M; Sveinbjornsson B; Kosalai ST; Baryawno N; Johnsen JI; Sakaguchi K; Kanduri C; Martinsson T; Kogner P
- Conference publication: PEDIATRIC BLOOD & CANCER. 2016;63:S82-S83Kock A; Larsson K; Eissler N; Bergqvist F; Elfman L; Raouf J; Korotkova M; Johnsen JI; Jakobsson PJ; Kogner P
- Conference publication: PEDIATRIC BLOOD & CANCER. 2016;63:S28Eissler N; Mao Y; Brodin D; Reutersward P; Svahn HA; Johnsen JI; Kiessling R; Kogner P
- Conference publication: NEURO-ONCOLOGY. 2016;18:116Ljungblad L; Bergqvist F; Andonova T; Jakobsson P-J; Johnsen JI; Gleissman H; Kogner P; Wickstrom M
- Conference publication: PEDIATRIC BLOOD & CANCER. 2015;62:S328-S329Dyberg C; Forsberg D; Fransson S; Lannerholm-Palm J; Sveinbjornsson B; Martinsson T; Kogner P; Johnsen JI; Wickstrom M
- Conference publication: PEDIATRIC BLOOD & CANCER. 2015;62:S332Milosevic J; Treis D; Malin M; Fransson S; Sveinbjornsson B; Eissler N; Baryawno N; Tanino K; Selivanova G; Sakaguchi K; Martinsson T; Johnsen JI; Kogner P
- Conference publication: PEDIATRIC BLOOD & CANCER. 2015;62:S149Eissler N; Mao Y; Johnsen JI; Kiessling R; Kogner P
- Conference publication: CANCER RESEARCH. 2015;75:3266Dyberg C; Forsberg D; Fransson S; Palm JL; Haug BH; Sveinbjornsson B; Martinsson T; Kogner P; Johnsen JI; Wickstrom M
- Conference publication: CANCER RESEARCH. 2015;75:503Miloseyic J; Treis D; Wickstrom M; Fransson S; Eissler N; Syeinbjornsson B; Baryawno N; Tanino K; Selivanova G; Sakaguchi K; Martinsson T; Johnsen JI; Kogner P
- Conference publication: CANCER RESEARCH. 2015;75:3279Tuemmler C; Snapkov I; Moens UL; Kogner P; Johnsen JI; Sveinbjornsson B
- Conference publication: CANCER RESEARCH. 2015;75:3283Snapkov I; Oqvist CO; Figenschau YA; Kogner P; Johnsen JI; Sveinbjornsson B
- Conference publication: CANCER RESEARCH. 2015;75:1632Kock A; Larsson K; Joan R; Korotkova M; Johnsen J-I; Jakobsson P-J; Kogner P
- Conference publication: CANCER RESEARCH. 2015;75:3275Ljungblad LM; Johnsen J-I; Wickstrom M; Kogner P; Gleissman H
- Review: WORLD JOURNAL OF EXPERIMENTAL MEDICINE. 2015;5(1):1-10Söderberg-Nauclér C; Johnsen JI
- Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2014;50:135Chen ZX; Wallis K; Fell SM; Sobrado VR; Hemmer MC; Ramskold D; Choo Z; Hellman U; Sandberg R; Kenchappa RS; Martinsson T; Johnsen JI; Kogner P; Schlisio S
- Conference publication: CANCER RESEARCH. 2014;74(20):a84Krona C; Dyberg C; Sanden E; Darabi A; Wickstrom M; Northcott P; Johnsen JI; Siesjo P
- Meeting abstract: CANCER RESEARCH. 2014;74(19):3110Dyberg C; Forsberg D; Papachristou P; Lannerholm-Palm J; Haug BH; Sveinbjoernsson B; Lagercrantz H; Kogner P; Johnsen JI; Wickstrom M
- Conference publication: CANCER RESEARCH. 2014;74(19):3971Milosevic J; Wickstrom M; Treis D; Nordegren HS; Elfman L; Baryawno N; Fransson S; Sveinbjornsson B; Martinsson T; Johnsen JI; Kogner P
- Conference publication: CANCER RESEARCH. 2014;74(19):3976Snapkov I; Kogner P; Johnsen J-I; Sveinbjornsson B
- Conference publication: CANCER RESEARCH. 2014;74(19):3988Ljungblad LM; Wickstrom M; Johnsen J-I; Kogner P; Gleissman H
- Meeting abstract: CANCER RESEARCH. 2014;74(19):3986Kock A; Larsson K; Ljungblad L; Idborg H; Korotkova M; Elfman L; Johnsen J-I; Jakobsson P-J; Kogner P
- Letter: BRITISH JOURNAL OF CANCER. 2013;108(10):2191Hiyoshi H; Johnsen JI; Andang M; Uhlen P
- Meeting abstract: CANCER RESEARCH. 2013;73(8):3795Dyberg CH; Papachristou P; Lagercrantz H; Johnsen JI; Wickstrom M
- Conference publication: CANCER RESEARCH. 2013;73(8):3817Milosevic J; Wickstrom M; Elfman L; Baryawno N; Sveinbjornsson B; Martinsson T; Johnsen JI; Kogner P
- Conference publication: NEURO-ONCOLOGY. 2013;15:18Marino A-M; Baryawno N; Johnsen J-I; Ostman A
- Editorial comment: ONCOIMMUNOLOGY. 2012;1(5):739-740Soderberg-Naucler C; Johnsen JI
- Conference publication: NEURO-ONCOLOGY. 2012;14:102Milosevic J; Baryawno N; Sveinbjornsson B; Martinsson T; Grotzer M; Johnsen JI; Kogner P
- Conference publication: NEURO-ONCOLOGY. 2012;14:99-100Marino A-M; Baryawno N; Ekstrom TP; Ostman A; Johnsen J-I
- Conference publication: CANCER RESEARCH. 2012;72:825Dyberg CH; Baryawno N; Milosevic J; Wickstrom M; Sveinbjornsson B; Northcott PA; Taylor MD; Kool M; Kogner P; Johnsen JI
- Conference publication: CANCER RESEARCH. 2012;72:2499Milosevic J; Baryawno N; Syeinbjornsson B; Martinsson T; Johnsen JI; Kogner P
- Meeting abstract: CANCER RESEARCH. 2012;72:1420Kock A; Rasmuson A; Idborg H; Johnsen JI; Kogner P
- Conference publication: CANCER RESEARCH. 2012;72:4725Wickstrom M; Dyberg C; Shimokawa T; Baryawno N; Milosevic J; Fuskevag OM; Larsson R; Zaphiropoulos PG; Kogner P; Johnsen JI
- Conference publication: NEURO-ONCOLOGY. 2011;13:I9Marino AM; Johnsen J-I; Ekstrom TJ; Zaphiropoulos P; Ostman A
- Conference publication: CANCER RESEARCH. 2011;71:lb-209-lb-209Milosevic J; Baryawno N; Dyberg C; Wickstrom M; Sveinbjornsson B; Northcott PA; Taylor MD; Kool M; Kogner P; Johnsen JI
- Review: EXPERIMENTAL CELL RESEARCH. 2010;316(8):1365-1373Gleissman H; Johnsen JI; Kogner P
- Corrigendum: CANCER RESEARCH. 2010;70(5):2138-2139Baryawno N; Sveinbjornsson B; Eksborg S; Chen C-S; Kogner P; Johnsen JI
- Review: MECHANISMS AND THERAPY OF LIVER CANCER. 2010;107:163-224Albihn A; Johnsen JI; Henriksson MA
- Conference publication: PEDIATRIC BLOOD & CANCER. 2009;53(5):807Kogner P; Gleissman H; Serhan CN; Hamberg M; Segerstrom L; Lindskog M; Johnsen JI
- Conference publication: CANCER RESEARCH. 2009;69Milosevic J; Baryawno N; Sveinbjornsson B; Eksborg S; Holm S; Johnsen J-I; Kogner P
- Conference publication: CANCER RESEARCH. 2009;69Ninib B; Sveinbjornsson B; Eksborg S; Chen C-S; Kogner P; Johnsen J-I
- Conference publication: CANCER RESEARCH. 2009;69Neuroblastoma cells produce PGE2 and express all four PGE2 receptors: Implications for tumorigenesisRasmuson A; Johnsen JI; Koshnevis M; Simon-SantaMaria J; Elfman L; Fuskevag OM; Orrego A; Kogner P; Sveinbjornsson B
- Conference publication: CANCER RESEARCH. 2009;69Palmberg E; Rickardson L; Johnsen JI; Kogner P; Lindskog M
- Review: APOPTOSIS. 2009;14(4):424-438Johnsen JI; Kogner P; Albihn A; Henriksson MA
- Conference publication: NEURO-ONCOLOGY. 2008;10(3):515Baryawno N; Sveinbjbornsson B; Eksborg S; Orrego A; Segerstrom L; Oqvist CO; Holm S; Gustavsson B; Kagedal B; Kogner P; Johnsen JI
- Conference publication: NEURO-ONCOLOGY. 2008;10(3):506Baryawno N; Sveinbjornsson B; Eksborg S; Kogner P; Johnsen JI
- Meeting abstract: CYTOKINE. 2007;39(1):33Pettersen I; Bakkelund WH; Winberg J-O; Johnsen JI; Kogner P; Sveinbjornsson B
- Conference publication: NEURO-ONCOLOGY. 2007;9(2):197Baryawno N; Sveinbjornsson B; Holm S; Orrego A; Gustavsson B; Johnsen JI; Kogner P
- Conference publication: CANCER RESEARCH. 2006;66(8)Baryawno N; Sveinbjornsson B; Holm S; Orrego A; Gustavsson B; Kogner P; Johnsen JI
- Conference publication: CANCER RESEARCH. 2006;66(8)Rasmuson A; Johnsen JI; Orrego A; Kogner P; Sveinbjornsson B
- Conference publication: CANCER RESEARCH. 2006;66(8)Gleissman H; Lindskog M; Ponthan F; Elfman L; Johnsen JI; Kogner P
- Conference publication: PROSTAGLANDINS & OTHER LIPID MEDIATORS. 2006;79(1-2):185Sveinbjörnsson B; Johnsen JI; Rasmuson A; Pettersen I; Orrego A; Phontan F; Elfnan L; Kogner P
- Review: CANCER LETTERS. 2005;228(1-2):247-255Lindskog M; Spenger C; Klason T; Jarvet J; Gräslund A; Johnsen JI; Ponthan F; Douglas L; Nordell B; Kogner P
- Review: CANCER LETTERS. 2005;228(1-2):195-201Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
- Published conference paper: PEDIATRIC BLOOD & CANCER. 2000;35(6):593-596Jorgensen GEK; Johnsen JI; Ponthan F; Kogner P; Flægstad T; Traavik T
- Review: VIRUS GENES. 1995;10(3):261-275MOENS U; JOHANSEN T; JOHNSEN JI; SETERNES OM; TRAAVIK T
- Show more
Grants
- Barncancerfonden1 January 2023 - 31 December 2023
- Swedish Cancer Society1 January 2022Medulloblastoma and neuroblastoma are tumors that develop in the nervous system and are the most common solid tumors in children. Often the tumors respond poorly to the treatment given and the mortality rate is high. The need to develop more effective treatment is great. Solid tumors can be considered heterogeneous entities consisting of tumor cells with different degrees of differentiation or maturity. Individual cells in these tumors resemble normal stem cells in the body, with the ability to renew themselves while simultaneously maturing and developing into different cell types. From a treatment point of view, these cells are important as they are resistant to various treatments. The project aims to identify new molecules for targeted therapy and to characterize the microenvironment in medulloblastoma and neuroblastoma, with the goal of developing more effective therapies. To make this possible, increased knowledge of the tumor cell's molecular pathology is required. By using molecular biological techniques to study how medulloblastoma and neuroblastoma cells differ from normal cells in the nervous system and how the tumor cells contribute to the establishment of a microenvironment that favors tumor formation, we hope to find molecular signatures specific to tumor cells and to find specific drugs that kill these cells . We want to find new molecular targets for therapy that can lead to better survival and fewer side effects for children with medulloblastoma and neuroblastoma. We want to try to understand how the cancer cell interacts with the surrounding normal cells and how a microenvironment that supports the tumor's growth and spread arises. The ultimate goal is to cure the majority of children with medulloblastoma and neuroblastoma.
- New therapy for medulloblastoma and neuroblastomaSwedish Cancer Society1 January 2018Medulloblastoma and neuroblastoma are tumors that develop in the nervous system and are the most common solid tumors in children. The tumors often respond poorly to the treatment given, and mortality is high. The need to develop more efficient treatment is great. Solid tumors can be considered as heterogeneous entities including tumor cells with varying degrees of differentiation or maturity. Single cells in medulloblastoma are similar to normal stem cells in the body, with the ability to renew themselves and at the same time mature and develop into different cell types. From a therapeutic point of view, these cells are of importance as they are resistant to various treatments. The project aims to identify new molecules for targeted therapy and to characterize the microenvironment in medulloblastoma and neuroblastoma, with the aim of developing more effective therapies. To enable this, extended knowledge of the tumor cell's molecular pathology is required. When using molecular biological techniques to study how medulloblastoma and neuroblastoma cells differ from normal cells in the nervous system and how the tumor cells contribute to the establishment of microenvironment that benefits tumor formation, we hope to find molecular signatures specific to tumor cells and to find specific drugs that kill these cells. The ultimate goal is to find new molecular targets for therapy that can lead to better survival and less side effects for children with medulloblastoma and neuroblastoma. We want to try to understand how the cancer cell interacts with the surrounding normal cells and how a microenvironment that supports the growth and spread of the tumor occurs.
- New therapy for medulloblastoma and neuroblastomaSwedish Cancer Society1 January 2017Medulloblastoma and neuroblastoma are tumors that develop in the nervous system and are the most common solid tumors in children. The tumors often respond poorly to the treatment given, and mortality is high. The need to develop more efficient treatment is great. Solid tumors can be considered as heterogeneous entities including tumor cells with varying degrees of differentiation or maturity. Single cells in medulloblastoma are similar to normal stem cells in the body, with the ability to renew themselves and at the same time mature and develop into different cell types. From a therapeutic point of view, these cells are of importance as they are resistant to various treatments. The project aims to identify new molecules for targeted therapy and to characterize cancer stem cells in medulloblastoma and neuroblastoma, with the aim of developing more effective therapies. To enable this, extended molecular knowledge of the tumor cell's molecular pathology is required. When using molecular biological techniques to study how medulloblastoma and neuroblastoma cells differ from normal cells in the nervous system and how the tumor cells contribute to the establishment of microenvironment that benefits tumor formation, we hope to find molecular signatures specific to tumor cells and to find specific drugs that kill these cells. . The ultimate goal is to find new molecular targets for therapy that can lead to better survival and less side effects for children with medulloblastoma and neuroblastoma. We want to try to understand how the cancer cell interacts with the surrounding normal cells and how a microenvironment that supports the growth and spread of the tumor occurs. We also want to try to characterize cancer stem cells in these child tumors and find new treatments that are specifically corrected for these cells.
- New therapy for medulloblastoma and neuroblastomaSwedish Cancer Society1 January 2016Medulloblastoma and neuroblastoma are tumors that develop in the nervous system and are the most common solid tumors in children. The tumors often respond poorly to the treatment given, and mortality is high. The need to develop more efficient treatment is great. Solid tumors can be considered as heterogeneous entities including tumor cells with varying degrees of differentiation or maturity. Single cells in medulloblastoma are similar to normal stem cells in the body, with the ability to renew themselves and at the same time mature and develop into different cell types. From a therapeutic point of view, these cells are of importance as they are resistant to various treatments. The project aims to identify new molecules for targeted therapy and to characterize cancer stem cells in medulloblastoma and neuroblastoma, with the aim of developing more effective therapies. To enable this, extended molecular knowledge of the tumor cell's molecular pathology is required. When using molecular biological techniques to study how medulloblastoma and neuroblastoma cells differ from normal cells in the nervous system and how the tumor cells contribute to the establishment of microenvironment that benefits tumor formation, we hope to find molecular signatures specific to tumor cells and to find specific drugs that kill these cells. . The ultimate goal is to find new molecular targets for therapy that can lead to better survival and less side effects for children with medulloblastoma and neuroblastoma. We want to try to understand how the cancer cell interacts with the surrounding normal cells and how a microenvironment that supports the growth and spread of the tumor occurs. We also want to try to characterize cancer stem cells in these child tumors and find new treatments that are specifically corrected for these cells.
- New therapy for medulloblastoma and neuroblastomaSwedish Cancer Society1 January 2015Medulloblastoma and neuroblastoma are tumors that develop in the nervous system and are the most common solid tumors in children. The tumors often respond poorly to the treatment given, and mortality is high. The need to develop more efficient treatment is great. Solid tumors can be considered as heterogeneous entities including tumor cells with varying degrees of differentiation or maturity. Single cells in medulloblastoma are similar to normal stem cells in the body, with the ability to renew themselves and at the same time mature and develop into different cell types. From a therapeutic point of view, these cells are of importance as they are resistant to various treatments. The project aims to identify new molecules for targeted therapy and to characterize cancer stem cells in medulloblastoma and neuroblastoma, with the aim of developing more effective therapies. To enable this, extended molecular knowledge of the tumor cell's molecular pathology is required. When using molecular biological techniques to study how medulloblastoma and neuroblastoma cells differ from normal cells in the nervous system and how the tumor cells contribute to the establishment of microenvironment that benefits tumor formation, we hope to find molecular signatures specific to tumor cells and to find specific drugs that kill these cells. . The ultimate goal is to find new molecular targets for therapy that can lead to better survival and less side effects for children with medulloblastoma and neuroblastoma. We want to try to understand how the cancer cell interacts with the surrounding normal cells and how a microenvironment that supports the growth and spread of the tumor occurs. We also want to try to characterize cancer stem cells in these child tumors and find new treatments that are specifically corrected for these cells.
- Novel Neuroblastoma Biomarkers of Clinical RelevanceSwedish Foundation for Strategic Research1 January 2015 - 31 December 2019
- Targeted therapy for children with medulloblastomaSwedish Cancer Society1 January 2014Medulloblastoma is an embryonic tumor that develops in the central nervous system and is the most common brain tumor in children. In many cases, the tumors respond poorly to the treatment given and mortality is high. In addition, today's treatment often causes severe physical and cognitive problems for the patient. There is therefore a great need to develop more efficient treatments. The project aims to identify new molecules for targeted therapy and to characterize cancer stem cells in medulloblastoma. A subpopulation of cells in the tumor has features similar to those of normal stem cells in the body, with the ability to renew themselves and at the same time mature and develop into different cell types. Cancer stem cells are believed to have the capacity to establish and drive cancer development. From a therapeutic point of view, these cells are probably of great importance as they have proved very resistant to various treatments. To enable the development of more effective therapies, increased molecular knowledge of tumor cells with stem cell properties is required. The ultimate goal of developing more effective therapies based on biological understanding for children with medulloblastoma. In using molecular biological techniques to study how medulloblastoma cells differ from normal cells in the brain, we hope to find molecular signatures specific to different subgroups of medulloblastoma and to be able to recapitulate these in preclinical models. This allows to find new molecular targets for therapy that can lead to better survival and less side effects for children with medulloblastoma.
- Swedish Research Council1 January 2009 - 31 December 2011
Employments
- Principal Researcher, Department of Women's and Children's Health, Karolinska Institutet, 2022-
Degrees and Education
- Docent, Karolinska Institutet, 2010